R&D Partner Content Unlocking the Potential of Targeting the Innate Immune Syste... Ready to Catalyze the Next Wave of Inflammasome Therapies?
Market Access Partner Content The Inaugural Market Access for CNS Therapeutics Summit Has ... The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...
Partner Content Partner Content 5th Oligonucleotides for CNS Summit The Oligonucleotides for CNS Summit returns for its 5th year to address key challenges in durability, scalability, potency and CNS tropism
R&D Partner Content 2nd ADC & Novel Conjugates Partnering & Investment Summit Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADCconference calendar
R&D Partner Content Network With EHS Professionals - EHS&S for Biopharma West Advancing Biosafety & Sustainability in R&D & Manufacturing
R&D Partner Content Welcome to the 2nd Raw Materials for Cell & Gene Therapy Sum... Streamline Supply Chain Communications to Optimize Phase Appropriate QC Testing, Comparability & GMP Manufacturing of Raw Materials...
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
